Further particularly contemplated are pharmaceutical compositions for use in the treatment of patients recently exposed to {HEAD ~ HIV}, but not yet tested for or confirmed to be HIV positive by standard diagnostic procedures , {TAIL ~ patients} at risk of exposure to HIV, or patients already infected with HIV, i.e., HIV positive patients 
Further particularly contemplated are pharmaceutical compositions for use in the treatment of patients recently exposed to { HEAD ~ HIV } , but not yet tested for or confirmed to be HIV positive by standard diagnostic procedures , { TAIL ~ patients } at risk of exposure to HIV , or patients already infected with HIV , i.e. , HIV positive patients
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH